Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine
Objective(s):P In vitro chemosensitivity and resistance assays (CSRAs) are a promising tool for personalized treatment of glioblastoma multiform (GBM). These assays require a minimum of 1 to 2 g of tumor specimen for testing, but this amount is not always accessible. We aimed to assess the feasibili...
Main Authors: | Fariba Sadeghi Fazel, Mahnaz Haddadi, Alireza Khoshnevisan, Samad Muhammadnejad, Ahad Muhammadnejad, Zohreh Mazaheri, Motahareh Arjomandnejad, Reza Shirkoohi, Mohammad-Ali Oghabian, Narjes Sherkat-Khameneh, Saeid Amanpour, Monireh Kazemimanesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2014-11-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/pdf_3747_18889a2b2c356f4ab92fad027b03e2be.html |
Similar Items
-
Studying angiogenesis in autochthonous xenograft models of glioblastoma multiforme by MVD-CD34 technique in Iranian patients
by: Amanpour S, et al.
Published: (2011-06-01) -
Establishment of Autochthonous & Standard Cell Line Derived Xenograft Models of Glioblastoma Multiform in Iran
by: Ali-Reza Khoshnevisan, et al.
Published: (2011-02-01) -
Chemoresponse Assay in Head and Neck Cancer Patients: A Three-Year Follow Up
by: Basem T Jamal, et al.
Published: (2017-05-01) -
AGS cell line xenograft tumor as a suitable gastric adenocarcinoma model: growth kinetic characterization and immunohistochemistry analysis
by: Tahereh Barati, et al.
Published: (2018-07-01) -
Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness
by: Archana Thakur, et al.
Published: (2021-01-01)